Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Biomaterials. 2021 Nov 30;280:121297. doi: 10.1016/j.biomaterials.2021.121297

Figure 2: Biomaterial-based vaccine strategies.

Figure 2:

Therapeutic vaccine modalities can be divided into two main categories dependent on primary material modality. Particulate-based vaccines (left) include nanoparticle, including liposomes, and extracellular vesicles such as exosomes. Polymer-based vaccines (right) can either be biodegradable or non-degradable and can be composed of polymers, hydrogels or silica rods.